Related Experiment Videos

Metronidazole gel in managing malodorous fungating wounds

Jane Clark1

  • 1Crosshouse Hospital, Ayrshire and Arran Acute Hospital NHS Trust.

British Journal of Nursing (Mark Allen Publishing)
|April 30, 2002
PubMed

Insights

Fungating wounds, often seen in palliative care, present challenges, particularly malodour. This review explores metronidazole preparations as a potential management strategy for these distressing symptoms.

Area of Science:

  • Palliative Care
  • Wound Management
  • Oncology Nursing

Background:

  • Fungating wounds are uncommon, with limited incidence data available, particularly in the UK.
  • These wounds typically indicate advanced disease and are associated with palliative care needs.
  • Effective symptom management is crucial as fungating wounds rarely heal.

Purpose of the Study:

  • To review the limited research on metronidazole preparations for managing malodour in fungating wounds.
  • To highlight the impact of malodour as a distressing symptom for patients with fungating wounds.

Main Methods:

  • Literature review of existing research on fungating wounds and malodour management.
  • Focus on studies investigating metronidazole preparations for wound malodour.

Main Results:

  • The incidence and impact of fungating wounds remain poorly documented.
  • Malodour is a significant and distressing symptom for patients with fungating wounds.
  • Research on metronidazole for wound malodour is limited but suggests potential utility.

Conclusions:

  • There is a need for more research into the effective management of fungating wounds, especially concerning malodour.
  • Metronidazole preparations warrant further investigation as a treatment option for malodorous fungating wounds in palliative care settings.

Related Concept Videos